1. Planning Benchmark Study for Stereotactic Body Radiation Therapy of Liver Metastases: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery.
- Author
-
Moustakis, Christos, Blanck, Oliver, Chan, Mark ka heng, Boda-Heggemann, Judit, Andratschke, Nicolaus, Duma, Marciana-Nona, Albers, Dirk, Bäumer, Christian, Fehr, Roman, Körber, Stefan A., Schmidhalter, Daniel, Alraun, Manfred, Baus, Wolfgang W., Beckers, Eric, Dierl, Mathias, Droege, Stephan, Ebrahimi Tazehmahalleh, Fatemeh, Fleckenstein, Jens, Guckenberger, Matthias, and Heinz, Christian
- Subjects
- *
STEREOTACTIC radiotherapy , *RADIOTHERAPY treatment planning , *RADIOTHERAPY , *RADIOSURGERY , *COMPUTERS in medicine , *LIVER tumors , *BENCHMARKING (Management) , *RADIATION doses - Abstract
Purpose: Our purpose was to investigate whether liver stereotactic body radiation therapy treatment planning can be harmonized across different treatment planning systems, delivery techniques, and institutions by using a specific prescription method and to minimize the knowledge gap concerning intersystem and interuser differences. We provide best practice guidelines for all used techniques.Methods and Materials: A multiparametric specification of target dose (gross target volume [GTV]D50%, GTVD0.1cc, GTVV90%, planning target volume [PTV]V70%) with a prescription dose of GTVD50% = 3 × 20 Gy and organ-at-risk (OAR) limits were distributed with computed tomography and structure sets from 3 patients with liver metastases. Thirty-five institutions provided 132 treatment plans using different irradiation techniques. These plans were first analyzed for target and OAR doses. Four different renormalization methods were performed (PTVDmin, PTVD98%, PTVD2%, PTVDmax). The resulting 660 treatments plans were evaluated regarding target doses to study the effect of dose renormalization to different prescription methods. A relative scoring system was used for comparisons.Results: GTVD50% prescription can be performed in all systems. Treatment plan harmonization was overall successful, with standard deviations for Dmax, PTVD98%, GTVD98%, and PTVDmean of 1.6, 3.3, 1.9, and 1.5 Gy, respectively. Primary analysis showed 55 major deviations from clinical goals in 132 plans, whereas in only <20% of deviations GTV/PTV dose was traded for meeting OAR limits. GTVD50% prescription produced the smallest deviation from target planning objectives and between techniques, followed by the PTVDmax, PTVD98%, PTVD2%, and PTVDmin prescription. Deviations were significant for all combinations but for the PTVDmax prescription compared with GTVD50% and PTVD98%. Based on the various dose prescription methods, all systems significantly differed from each other, whereas GTVD50% and PTVD98% prescription showed the least difference between the systems.Conclusions: This study showed the feasibility of harmonizing liver stereotactic body radiation therapy treatment plans across different treatment planning systems and delivery techniques when a sufficient set of clinical goals is given. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF